Sandbox/00022
< Sandbox
Evaluation of secondary hypertension | |||||||||||||||||||||||||||||||||
Investigation should be limited for patients with clues suggestive of potentially correctable causes. ❑ Presence of clues for renovascular hypertension (most common potentially correctable cause)?[1][2]
| |||||||||||||||||||||||||||||||||
YES | NO | ||||||||||||||||||||||||||||||||
❑ Perform noninvasive diagnostic studies
| Look for findings suggestive of other identifiable causes ❑ Pheochromocytoma
❑ Hyperaldosteronism
❑ Obstructive sleep apnea
❑ Hyperparathyroidism
❑ Hypothyroidism
❑ Aortic coarctation
| ||||||||||||||||||||||||||||||||
References
- ↑ Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL; et al. (2006). "ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation". Circulation. 113 (11): e463–654. doi:10.1161/CIRCULATIONAHA.106.174526. PMID 16549646.
- ↑ Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK; et al. (2011). "2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 58 (19): 2020–45. doi:10.1016/j.jacc.2011.08.023. PMID 21963765.